Embolization and Coiling Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4267748
  • Report
  • 117 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Aneuclose LLC
  • Collagen Matrix Inc
  • Insera Therapeutics, LLC
  • MicroPort Scientific Corp
  • MiVi Neuroscience, LLC
  • Taewoong Medical Co Ltd
  • MORE
Embolization and Coiling Devices - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Embolization and Coiling Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Embolization and Coiling Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Embolization and Coiling Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Embolization and Coiling Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Embolization and Coiling Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Embolization and Coiling Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aneuclose LLC
  • Collagen Matrix Inc
  • Insera Therapeutics, LLC
  • MicroPort Scientific Corp
  • MiVi Neuroscience, LLC
  • Taewoong Medical Co Ltd
  • MORE
1 Table of Contents
2 Introduction
2.1 Embolization and Coiling Devices Overview
3 Products under Development
3.1 Embolization and Coiling Devices - Pipeline Products by Stage of Development
3.2 Embolization and Coiling Devices - Pipeline Products by Segment
3.3 Embolization and Coiling Devices - Pipeline Products by Territory
3.4 Embolization and Coiling Devices - Pipeline Products by Regulatory Path
3.5 Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date
3.6 Embolization and Coiling Devices - Ongoing Clinical Trials
4 Embolization and Coiling Devices - Pipeline Products under Development by Companies
4.1 Embolization and Coiling Devices Companies - Pipeline Products by Stage of Development
4.2 Embolization and Coiling Devices - Pipeline Products by Stage of Development
5 Embolization and Coiling Devices Companies and Product Overview
5.1 Aneuclose LLC Company Overview
5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Avantec Vascular Corporation Company Overview
5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.3 BioCure, Inc. Company Overview
5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Collagen Matrix Inc Company Overview
5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 DePuy Synthes Inc Company Overview
5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Insera Therapeutics, LLC Company Overview
5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Medtronic plc Company Overview
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.8 MicroPort Scientific Corp Company Overview
5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 MicroVention, Inc. Company Overview
5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 MiVi Neuroscience, LLC Company Overview
5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Neuravi Ltd Company Overview
5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Shape Memory Therapeutics, Inc. Company Overview
5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Taewoong Medical Co Ltd Company Overview
5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Terumo Corp Company Overview
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 University of California Los Angeles Company Overview
5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.16 University of Minnesota Company Overview
5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.17 University of Wisconsin Madison Company Overview
5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
5.18 Valor Medical Inc Company Overview
5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Vascular Solutions Inc Company Overview
5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Embolization and Coiling Devices- Recent Developments
6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results
6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
6.4 Apr 25, 2017: Stryker reports first quarter 2017 results
6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors
6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results
6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results
6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results
6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study
6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results
6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke
6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016
6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers
6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon
6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results
6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care
6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors
6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy
6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer
6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member
6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results
6.30 Oct 27, 2016: Stryker reports third quarter 2016 results
6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.32 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results
6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters
6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results
6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results
6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
6.43 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director
6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results
6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
6.47 Jul 21, 2016: Stryker reports second quarter 2016 results
6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing
6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations
6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
7 Appendix
7.1 Methodology

List of Tables
Table 1: Embolization and Coiling Devices - Pipeline Products by Stage of Development
Table 2: Embolization and Coiling Devices - Pipeline Products by Segment
Table 3: Embolization and Coiling Devices - Pipeline Products by Territory
Table 4: Embolization and Coiling Devices - Pipeline Products by Regulatory Path
Table 5: Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date
Table 6: Embolization and Coiling Devices - Ongoing Clinical Trials
Table 7: Embolization and Coiling Devices Companies - Pipeline Products by Stage of Development
Table 8: Embolization and Coiling Devices - Pipeline Products by Stage of Development
Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Janjua Aneurysm Net - Product Status
Table 11: Janjua Aneurysm Net - Product Description
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Endovascular Embolization Device - Product Status
Table 14: Endovascular Embolization Device - Product Description
Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: GelCoil - Product Status
Table 17: GelCoil - Product Description
Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Collagen-based Coils - Product Status
Table 20: Collagen-based Coils - Product Description
Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Liquid Embolic System - Product Status
Table 23: Liquid Embolic System - Product Description
Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 25: SHELTER - Product Status
Table 26: SHELTER - Product Description
Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Medina Embolization Device - Product Status
Table 29: Medina Embolization Device - Product Description
Table 30: UNO Neurovascular Embolization System - Product Status
Table 31: UNO Neurovascular Embolization System - Product Description
Table 32: Medtronic plc - Ongoing Clinical Trials Overview
Table 33: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study
Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Embolization Coils - Product Status
Table 36: Embolization Coils - Product Description
Table 37: MicroPort Scientific Corp - Ongoing Clinical Trials Overview
Table 38: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms
Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Advanced Coil - Product Status
Table 41: Advanced Coil - Product Description
Table 42: Advanced WEB Aneurysm Embolization Device - Product Status
Table 43: Advanced WEB Aneurysm Embolization Device - Product Description
Table 44: WEB Aneurysm Embolization System - Product Status
Table 45: WEB Aneurysm Embolization System - Product Description
Table 46: MicroVention, Inc. - Ongoing Clinical Trials Overview
Table 47: WEB Aneurysm Embolization System - Clinical Assessment of Web Device in Ruptured Aneurysms
Table 48: WEB Aneurysm Embolization System - CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS
Table 49: WEB Aneurysm Embolization System - The WEB Intrasaccular Therapy Study (WEB-IT)
Table 50: WEB Aneurysm Embolization System - WEB Clinical Assessment of IntraSaccular Aneurysm Therapy
Table 51: WEB Aneurysm Embolization System - WEB French Observatory
Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Neuronet - Product Status
Table 54: Neuronet - Product Description
Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 56: EmboTrap II Revascularization Device - Product Status
Table 57: EmboTrap II Revascularization Device - Product Description
Table 58: EmboTrap Revascularization Device - Product Status
Table 59: EmboTrap Revascularization Device - Product Description
Table 60: Neuravi Ltd - Ongoing Clinical Trials Overview
Table 61: EmboTrap Revascularization Device - A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke with EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device
Table 62: EmboTrap Revascularization Device - ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap) Study
Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Neurovascular Embolization System - Product Status
Table 65: Neurovascular Embolization System - Product Description
Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 67: K3 Platium Coil - Product Status
Table 68: K3 Platium Coil - Product Description
Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 70: VFC /Hydrofill Coil - Product Status
Table 71: VFC /Hydrofill Coil - Product Description
Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Bioactive Endovascular Coil - Product Status
Table 74: Bioactive Endovascular Coil - Product Description
Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Vascular Embolization Catheter - Product Status
Table 77: Vascular Embolization Catheter - Product Description
Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Bioactive Endovascular Device - Product Status
Table 80: Bioactive Endovascular Device - Product Description
Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Neucrylate AN - Product Status
Table 83: Neucrylate AN - Product Description
Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Embolization Device - Product Status
Table 86: Embolization Device - Product Description
Table 87: Glossary

List of Figures
Figure 1: Embolization and Coiling Devices - Pipeline Products by Stage of Development
Figure 2: Embolization and Coiling Devices - Pipeline Products by Segment
Figure 3: Embolization and Coiling Devices - Pipeline Products by Territory
Figure 4: Embolization and Coiling Devices - Pipeline Products by Regulatory Path
Figure 5: Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date
Figure 6: Embolization and Coiling Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aneuclose LLC
  • Avantec Vascular Corporation
  • BioCure, Inc.
  • Collagen Matrix Inc
  • DePuy Synthes Inc
  • Insera Therapeutics, LLC
  • Medtronic plc
  • MicroPort Scientific Corp
  • MicroVention, Inc.
  • MiVi Neuroscience, LLC
  • Neuravi Ltd
  • Shape Memory Therapeutics, Inc.
  • Taewoong Medical Co Ltd
  • Terumo Corp
  • University of California Los Angeles
  • University of Minnesota
  • University of Wisconsin Madison
  • Valor Medical Inc
  • Vascular Solutions Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll